Kestra Medical Technologies, Ltd. (KMTS) Q1 2027 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of a loss of $0.61.
Kestra Medical Technologies NASDAQ: KMTS reported first-quarter fiscal 2027 revenue of $31 million, with President and Chief Executive Officer Brian Webster saying revenue rose 60% from a year earlier and advanced sequentially from the fourth quarter. The company raised its full-year revenue outlook to $141 million from a prior forecast of $137 million, representing expected growth of 48% over fiscal 2026.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Curtis Ellergodt Rothschild Investment LLC | 28 | $579.46 | $713.16 | $133.7 | 23.07% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 15,648 | $312,825.09 | $419,835.84 | $107,010.75 | 34.21% |
| GN Gina Nelson Next Century Growth Investors LLC | 458,505 | $11.67M | $12.96M | $1.29M | 11.02% |
| CD Charlie Durham Sterling Capital Management LLC | 94 | $2,242.39 | $2,394.18 | $151.79 | 6.77% |
Point72 Asset Management LP Point72 Asset Management LP | 526,626 | $10.75M | $15.1M | $4.36M | 40.55% |
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Brian Webster CEO | NASDAQ (NGS) Exchange | G52441105 CUSIP |
| US Country | 443 Employees | - Last Dividend | - Last Split | - IPO Date |
Kestra Medical Technologies, Ltd. is a pioneering company in the realm of wearable medical devices and digital healthcare solutions, rooted in the mission to enhance patient outcomes specifically regarding cardiovascular diseases. The organization was founded in 2014 and is located in Kirkland, Washington. Through the integration of innovative monitoring and therapeutic intervention technologies that are designed to be intuitive, intelligent, and connected, Kestra aims to revolutionize how cardiology is approached. The company centers its efforts on its flagship product, the Cardiac Recovery System platform, which unifies monitoring, therapeutic treatment, digital health, and patient support services into a comprehensive solution for managing cardiac health.
Kestra Medical Technologies offers an array of products and services designed to improve patient engagement and outcomes in the context of cardiovascular care. Below are the key components of their product offering:
The core of Kestra's offerings is the Cardiac Recovery System platform, which integrates advanced monitoring and therapeutic solutions tailored for patients at risk of heart-related incidents. This platform is geared towards creating a seamless experience for both patients and healthcare providers.
This device is an essential feature of the Cardiac Recovery System, designed specifically for patients who are at an increased risk of sudden cardiac arrest (SCA). It provides life-saving capabilities by continuously monitoring the heart's rhythms and delivering shock therapy when necessary, thereby protecting patients in critical situations.
Kestra also provides a suite of digital solutions that enhance patient and provider engagement. These tools facilitate real-time communication and support, allowing for proactive management of patient care and more informed decision-making by health professionals.
The company's offerings go beyond technology; they include robust patient support services aimed at ensuring adherence to therapy and providing guidance throughout the recovery process. This holistic approach is designed to empower patients in managing their cardiovascular health effectively.